Esperion Therapeutics, Inc. (NASDAQ:ESPR – Get Free Report) CFO Benjamin Halladay sold 7,337 shares of the stock in a transaction dated Wednesday, December 17th. The shares were sold at an average price of $3.67, for a total value of $26,926.79. Following the sale, the chief financial officer owned 467,525 shares of the company’s stock, valued […]

Esperion Therapeutics, Inc. (NASDAQ:ESPR – Get Free Report) General Counsel Benjamin Looker sold 6,517 shares of Esperion Therapeutics stock in a transaction that occurred on Wednesday, December 17th. The shares were sold at an average price of $3.67, for a total transaction of $23,917.39. Following the completion of the transaction, the general counsel directly owned […]

Amicus Therapeutics, Inc. (NASDAQ:FOLD – Get Free Report) insider David Michael Clark sold 25,643 shares of the stock in a transaction on Monday, December 15th. The stock was sold at an average price of $11.00, for a total value of $282,073.00. Following the transaction, the insider directly owned 271,332 shares in the company, valued at […]

Amicus Therapeutics, Inc. (NASDAQ:FOLD – Get Free Report) CEO Bradley Campbell sold 77,926 shares of Amicus Therapeutics stock in a transaction that occurred on Monday, December 15th. The shares were sold at an average price of $10.86, for a total transaction of $846,276.36. Following the completion of the transaction, the chief executive officer directly owned […]